RXi Pharmaceuticals Corp 4
4 · RXi Pharmaceuticals Corp · Filed Jun 26, 2017
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Purchase
Common stock, $0.0001 par value
2017-06-23$0.62/sh+3,500$2,170→ 3,500 total